Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 934-941

  Zhang, Shu Jing ^a   Endo, Sumio ^a   Ichikawa, Tomio ^a   Yoshimura, Junichi ^a   Onda, Kiyoshi ^a   Tanaka, Ryuichi ^a   Washiyama, Kazuo ^a   Kumanishi, Toshiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Glioma; MMAC1; Pseudogene; PTEN; Tumor suppressor gene

Indexed keywords

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE INSERTION; GENE MUTATION; GLIOMA CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MALE; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOGENE; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0032709006     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00838.x     Document Type: Article

References (36)

1. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F. and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15, 356-362 (1997).
2. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
3. Li, D.-M. and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57, 2124-2129 (1997).
4. Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R. and Tonks, N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 94, 9052-9057 (1997).
5. Maehama, T. and Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273, 13375-13378 (1998).
6. Furnari, F. B., Huang, H.-J. S. and Cavenee, W. K. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res., 58, 5002-5008 (1998).
7. Wang, S. I., Puc, J., Li, J., Bruce, J. N., Cairns, P., Sidransky, D. and Parsons, R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res., 57, 4183-4186 (1997).
8. Liu, W., James, C. D., Frederick, L., Alderete, B. E. and Jenkins, R. B. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res., 57, 5254-5257 (1997).
9. Chiariello, E., Roz, L., Albarosa, R., Magnani, I. and Finocchiaro, G. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene, 16, 541-545 (1998).
10. Rasheed, B. K. A., Stenzel, T. T., McLendon, R. E., Parsons, R., Friedman, A. H., Friedman, H. S., Bigner, D. D. and Bigner, S. H. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res., 57, 4187-4190 (1997).
11. Duerr, E.-M., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer-Puttlitz, B., Louis, D. N., Schramm, J., Wiestler, O. D., Parsons, R., Eng, C. and von Deimling, A. PTEN mutations in gliomas and glioneuronal tumors. Oncogene, 16, 2259-2264 (1998).
12. Maier, D., Zhang, Z., Taylor, E., Hamou, M-F., Gratzl, O., Van Meir, E. G., Scott, R. J. and Merlo, A. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene, 16, 3331-3335 (1998).
13. Furnari, F. B., Lin, H., Huang, H.-J. S. and Cavenee, W. K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA, 94, 12479-12484 (1997).
14. Teng, D. H.-F., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., Ellis, L., El-Naggar, A., Frazier, M., Jasser, S., Langford, L. A., Lee, J., Mills, G. B., Pershouse, M. A., Pollack, R. E., Tornos, C., Troncoso, P., Yung, W. K. A., Fujii, G., Berson, A., Bookstein, R., Bolen, J. B., Tavtigian, S. V. and Steck, P. A. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57, 5221-5225 (1997).
15. Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S. and Sidransky, D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000 (1997).
16. Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B. and Bova, G. S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res., 58, 204-209 (1998).
17. Kong, D., Suzuki, A., Zou, T.-T., Sakurada, A., Kemp, L. W., Wakatsuki, S., Yokoyama, T., Yamakawa, H., Furukawa, T., Sato, M., Ohuchi, N., Sato, S., Yin, J., Wang, S., Abraham, J. M., Souza, R. F., Smolinski, K. N., Meltzer, S. J. and Horii, A. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat. Genet., 17, 143-144 (1997).
18. Risinger, J. I., Hayes, A. K., Berchuck, A. and Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57, 4736-4738 (1997).
19. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. and Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57, 3935-3940 (1997).
20. James, C. D., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjold, M., Collins, V. P. and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48, 5546-5551 (1988).
21. Fults, D., Redone, C. A., Thomas, G. A. and White, R. Allelotype of human malignant astrocytoma. Cancer Res., 50, 5784-5789 (1990).
22. Rasheed, B. K. A., McLendon, R. E., Friedman, H. S., Friedman, A. H., Fuchs, H. E., Bigner, D. D. and Bigner, S. H. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene, 10, 2243-2246 (1995).
23. Kim, S. K., Su, L.-K., Oh, Y., Kemp, B. L., Hong, W. K. and Mao, L. Alterations of PTEN/MMAC1, a candidate tumour suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene, 16, 89-93 (1998).
24. Dahia, P. L. M., FitzGerald, M. G., Zhang, X., Marsh, D. J., Zheng, Z., Pietsch, T., von Deimling, A., Haluska, F. G., Haber, D. A. and Eng, C. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene, 16, 2403-2406 (1998).
25. Zhang, S.-J., Endo, S., Koga, H., Ichikawa, T., Feng, X.-L., Onda, K., Washiyama, K. and Kumanishi, T. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations. Jpn. J. Cancer Res., 87, 900-907 (1996).
26. Onda, K., Tanaka, R., Washiyama, K., Takeda, N. and Kumanishi, T. Correlation of DNA ploidy and morphological features of human glioma cell cultures with the establishment of cell lines. Acta Neuropathol., 76, 433-440 (1988).
27. Onda, K., Washiyama, K., Tanaka, R., Nishiyama, A., Usui, H. and Kumanishi, T. Establishment of human glioma cell lines with stable and unstable GFAP expression. Biomed. Res., 13, 327-334 (1992).
28. Yamazaki, K. Tumorigenicity of established human glioma cell lines in lasat and nude mice. Neuropathology, 3, 29-38 (1982) (in Japanese).
29. Bigner, D. D., Bigner, S. H., Ponten, J., Westermark, B., Mahaley, M. S., Jr., Ruoslahti, E., Herschman, H., Eng, L. F. and Wikstrand, C. J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol., 40, 201-229 (1981).
30. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
31. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C. and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16, 64-67 (1997).
32. Lynch, E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P. M., Kvinnsland, S., Gjertsen, B. T., Heimdal, K., Lubs, H., Moller, P. and King, M.-C. Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am. J. Hum. Genet., 61, 1254-1260 (1997).
33. Kohno, T., Takahashi, M., Manda, R. and Yokota, J. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosom. Cancer, 22, 152-156 (1998).
34. Gronbaek, K., Zeuthen, J., Guldberg, P., Ralfkiaer, E. and Hou-Jensen, K. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood, 19, 4388-4390 (1998).
35. FitzGerald, M. G., Marsh, D. J., Wahrer, D., Bell, D., Caron, S., Shannon, K. E., Ishioka, C., Isselbacher, K. J., Garber, J. E., Eng, C. and Haber, D. A. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene, 17, 727-731 (1998).
36. Guldberg, P., thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F. and Zeuthen, J. Disruption of the MMAC1/ PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57, 3660-3663 (1997).